These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9814993

  • 1. Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin.
    Agnello D, Bertini R, Sacco S, Meazza C, Villa P, Ghezzi P.
    Am J Physiol; 1998 Nov; 275(5):E757-62. PubMed ID: 9814993
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells.
    Charalampopoulos I, Androulidaki A, Minas V, Chatzaki E, Tsatsanis C, Notas G, Xidakis C, Kolios G, Kouroumalis E, Margioris AN, Gravanis A.
    Neuroendocrinology; 2006 Nov; 84(1):49-57. PubMed ID: 17090973
    [Abstract] [Full Text] [Related]

  • 3. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C, Androulidaki A, Dermitzaki E, Gravanis A, Margioris AN.
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [Abstract] [Full Text] [Related]

  • 4. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats.
    Czimmer J, Million M, Taché Y.
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G511-8. PubMed ID: 16223946
    [Abstract] [Full Text] [Related]

  • 5. Regulation of corticotropin-releasing factor receptor type 2beta messenger ribonucleic acid by interleukin-1beta in rat vascular smooth muscle cells.
    Kageyama K, Suda T.
    Neuroimmunomodulation; 2001 Mar; 9(6):326-32. PubMed ID: 12045360
    [Abstract] [Full Text] [Related]

  • 6. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids.
    Kageyama K, Bradbury MJ, Zhao L, Blount AL, Vale WW.
    Endocrinology; 1999 Dec; 140(12):5651-8. PubMed ID: 10579329
    [Abstract] [Full Text] [Related]

  • 7. Acotiamide attenuates central urocortin 2-induced intestinal inflammatory responses, and urocortin 2 treatment reduces TNF-α productions in LPS-stimulated macrophage cell lines.
    Yamawaki H, Futagami S, Sakasegawa N, Murakami M, Agawa S, Ikeda G, Noda H, Kirita K, Gudis K, Higuchi K, Kodaka Y, Ueki N, Iwakiri K.
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13813. PubMed ID: 32030855
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of one and repeated endotoxin treatment on pituitary- adrenocortical hormones in the mouse: role of interleukin-1 and tumor necrosis factor-alpha.
    Nagano I, Takao T, Nanamiya W, Takemura T, Nishiyama M, Asaba K, Makino S, De Souza EB, Hashimoto K.
    Neuroimmunomodulation; 1999 Aug; 6(4):284-92. PubMed ID: 10393514
    [Abstract] [Full Text] [Related]

  • 9. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
    [Abstract] [Full Text] [Related]

  • 10. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
    Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD, Latchman DS, Lee KF, Vale W.
    Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
    [Abstract] [Full Text] [Related]

  • 11. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat.
    Turnbull AV, Vaughan J, Rivier JE, Vale WW, Rivier C.
    Endocrinology; 1999 Jan; 140(1):71-8. PubMed ID: 9886809
    [Abstract] [Full Text] [Related]

  • 12. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects.
    Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL.
    Am J Pathol; 1991 Feb; 138(2):395-402. PubMed ID: 1992764
    [Abstract] [Full Text] [Related]

  • 13. Role of urocortin 2 secreted by the pituitary in the stress-induced suppression of luteinizing hormone secretion in rats.
    Nemoto T, Iwasaki-Sekino A, Yamauchi N, Shibasaki T.
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E567-75. PubMed ID: 20663987
    [Abstract] [Full Text] [Related]

  • 14. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary.
    Aubry JM, Turnbull AV, Pozzoli G, Rivier C, Vale W.
    Endocrinology; 1997 Apr; 138(4):1621-6. PubMed ID: 9075723
    [Abstract] [Full Text] [Related]

  • 15. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [Abstract] [Full Text] [Related]

  • 16. Urocortin increases IL-4 and IL-10 secretion and reverses LPS-induced TNF-alpha release from human trophoblast primary cells.
    Torricelli M, Voltolini C, Bloise E, Biliotti G, Giovannelli A, De Bonis M, Imperatore A, Petraglia F.
    Am J Reprod Immunol; 2009 Oct; 62(4):224-31. PubMed ID: 19703147
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone.
    Fantuzzi G, Demitri MT, Ghezzi P.
    Clin Exp Immunol; 1994 Apr; 96(1):166-9. PubMed ID: 8149662
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis.
    Zuckerman SH, Shellhaas J, Butler LD.
    Eur J Immunol; 1989 Feb; 19(2):301-5. PubMed ID: 2784766
    [Abstract] [Full Text] [Related]

  • 19. Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response.
    Novembri R, Carrarelli P, Toti P, Rocha AL, Borges LE, Reis FM, Piomboni P, Florio P, Petraglia F.
    Mol Hum Reprod; 2011 Sep; 17(9):587-93. PubMed ID: 21454316
    [Abstract] [Full Text] [Related]

  • 20. Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes.
    Ikeda K, Tojo K, Sato S, Ebisawa T, Tokudome G, Hosoya T, Harada M, Nakagawa O, Nakao K.
    Biochem Biophys Res Commun; 1998 Sep 18; 250(2):298-304. PubMed ID: 9753624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.